Measurement of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 after delayed separation of whole blood samples

Abstract

Objectives: Epidemiological studies benefit from unbiased blood specimens collected with minimal cost and effort of blood collection and storage. We evaluated the stability of IGF-1 and IGFBP-3 in whole blood samples stored at room temperature to justify delays in blood processing. Design and methods: Total IGF-1 and IGFBP-3 levels were measured in EDTA plasma ( n = 12), heparin plasma ( n = 12) and serum ( n = 10) samples of healthy volunteers after blood processing delays up till 14 days. Stability of measured IGF-1 and IGFBP-3 levels was tested by paired t-test and a linear mixed effect model. Results: Longitudinal analysis showed that IGF-1 levels were not significantly affected by blood processing delays in EDTA tubes ( p = 0.18) and IGFBP-3 levels were marginally stable ( p = 0.06). In heparin plasma and serum, however, IGF-1 increased over time of delayed processing and IGFBP-3 levels tended to decrease ( p < 0.01). Conclusion: Total IGF-1 and IGFBP-3 levels are stable in whole blood collected in EDTA tubes at room temperature up till 7 days, allowing a delay in blood processing to reduce costs in large multi-center studies.